Qualigen Therapeutics Inc (QLGN) — Free Cash Flow Generation Index

Latest as of September 2023: 1.27x

Qualigen Therapeutics Inc (QLGN) has a Free Cash Flow Generation Index of 1.27x as of September 2023. Free cash flow of $1.18 Million represents 1% of operating cash flow ($929.74K). Explore Qualigen Therapeutics Inc (QLGN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.27x

Free Cash Flow / Operating CF

Free Cash Flow

$1.18 Million

USD

Operating Cash Flow

$929.74K

USD

Capital Expenditures

$246.42K

USD

Qualigen Therapeutics Inc Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for Qualigen Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Qualigen Therapeutics Inc cash flow conversion.

Annual Free Cash Flow Generation for Qualigen Therapeutics Inc (2019–2019)

Year-by-year Free Cash Flow Generation Index for Qualigen Therapeutics Inc. Check total reinvestment intensity of Qualigen Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2019	-2.39x	$-137.15K	$57.33K	$194.48K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).